130 related articles for article (PubMed ID: 10938592)
1. [Proliferating cell nuclear antigen and p53 protein expression in submucosal invasive colorectal carcinoma].
Kanazawa Y; Onda M; Tanaka N; Seya T
J Nippon Med Sch; 2000 Aug; 67(4):242-9. PubMed ID: 10938592
[TBL] [Abstract][Full Text] [Related]
2. Proliferating cell nuclear antigen expression correlates with the metastatic potential of submucosal invasive colorectal carcinoma.
Tanaka S; Haruma K; Tatsuta S; Hiraga Y; Teixeira CR; Shimamoto F; Yoshihara M; Sumii K; Kajiyama G
Oncology; 1995; 52(2):134-9. PubMed ID: 7854773
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.
Hiraga Y; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F; Kohno N
Oncology; 1998; 55(4):307-19. PubMed ID: 9663420
[TBL] [Abstract][Full Text] [Related]
4. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
[TBL] [Abstract][Full Text] [Related]
5. Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive colorectal carcinomas.
Choi HJ; Jung IK; Kim SS; Hong SH
Dis Colon Rectum; 1997 Jan; 40(1):51-9. PubMed ID: 9102262
[TBL] [Abstract][Full Text] [Related]
6. Histologic grade and cellular proliferation at the deepest invasive portion correlate with the high malignancy of submucosal invasive gastric carcinoma.
Nishida T; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G
Oncology; 1995; 52(4):340-6. PubMed ID: 7777250
[TBL] [Abstract][Full Text] [Related]
7. Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas.
Teixeira CR; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G
Cancer; 1994 Feb; 73(3):575-9. PubMed ID: 7905362
[TBL] [Abstract][Full Text] [Related]
8. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
[TBL] [Abstract][Full Text] [Related]
10. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.
Georgescu CV; Săftoiu A; Georgescu CC; Ciurea R; Ciurea T
J Gastrointestin Liver Dis; 2007 Jun; 16(2):133-9. PubMed ID: 17592558
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen (PCNA) in relation to ras, c-erbB-2,p53, clinico-pathological variables and prognosis in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Stål O; Zhang H; Nordenskjöld B
Int J Cancer; 1996 Feb; 69(1):5-8. PubMed ID: 8600060
[TBL] [Abstract][Full Text] [Related]
12. [Significance of cancer cell growth and apoptosis in morphogenesis of colorectal cancer].
Seki H
Hokkaido Igaku Zasshi; 2000 Sep; 75(5):325-34. PubMed ID: 11070793
[TBL] [Abstract][Full Text] [Related]
13. Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type: an immunohistochemical study correlating grading, staging, and proliferation markers.
Haitel A; Wiener HG; Blaschitz U; Marberger M; Susani M
Cancer; 1999 Apr; 85(7):1593-8. PubMed ID: 10193951
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for recurrence in stage II and III gastric cancer patients receiving a curative resection and postoperative adjuvant chemotherapy.
Tsujinaka T; Shiozaki H; Yano M; Kikkawa N; Takami M; Monden M
Oncol Rep; 2001; 8(1):33-8. PubMed ID: 11115565
[TBL] [Abstract][Full Text] [Related]
15. Higher expression of oncoproteins c-myc, c-erb B-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors.
Yang JL; Ow KT; Russell PJ; Ham JM; Crowe PJ
Ann Surg Oncol; 1996 Nov; 3(6):574-9. PubMed ID: 8915491
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological evaluation of biological behavior of submucosal invasive gastric carcinomas: relationship among lymph node metastasis, mucin phenotype and proliferative activity.
Nakamoto J; Torisu R; Aoki R; Kimura Y; Yasuda M; Shiota K; Yamamoto Y; Ito S
J Med Invest; 2007 Feb; 54(1-2):99-108. PubMed ID: 17380020
[TBL] [Abstract][Full Text] [Related]
17. Expression of p53 protein in gastric cancer: an immunohistochemical study with correlation to proliferative activity.
Ioachim E; Goussia A; Stefanou D; Agnantis NJ
Anticancer Res; 1997; 17(1A):513-7. PubMed ID: 9066704
[TBL] [Abstract][Full Text] [Related]
18. A new cell proliferating marker: cytosolic thymidine kinase as compared to proliferating cell nuclear antigen in patients with colorectal carcinoma.
Wu J; Mao Y; He L; Wang N; Wu C; He Q; Skog S
Anticancer Res; 2000; 20(6C):4815-20. PubMed ID: 11205225
[TBL] [Abstract][Full Text] [Related]
19. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival.
Nakamura T; Tabuchi Y; Nakae S; Ohno M; Saitoh Y
Cancer; 1996 Apr; 77(8 Suppl):1741-6. PubMed ID: 8608572
[TBL] [Abstract][Full Text] [Related]
20. [Morphological atypism and clinicopathological factors in colorectal adenoma and cancer using nuclear DNA content, p53 and PCNA].
Yamamoto H; Yamada N; Asano G; Shoji T
Nihon Geka Gakkai Zasshi; 1994 Oct; 95(10):763-74. PubMed ID: 7823898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
